Radiation PneumonitisRadiotherapy, ConformalRadiation InjuriesRadiotherapy DosageRadiation OncologyDose FractionationRadiotherapyDose-Response Relationship, RadiationCombined Modality TherapyRadiation DosageRadiotherapy, Intensity-ModulatedLung NeoplasmsRadiosurgeryRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyMedical IllustrationRadiation, IonizingBrachytherapyCarcinoma, Non-Small-Cell LungAlveolitis, Extrinsic AllergicKrypton RadioisotopesRadiotherapy, AdjuvantCyclic AMP-Dependent Protein Kinase Type IRadiation Injuries, ExperimentalTreatment OutcomeCryptogenic Organizing PneumoniaKarnofsky Performance StatusMedical OncologyAntineoplastic Combined Chemotherapy ProtocolsChemoradiotherapyRadiation ToleranceOrgans at RiskSupratentorial NeoplasmsAndrogen AntagonistsSurvival AnalysisCranial IrradiationProstatic NeoplasmsHead and Neck NeoplasmsPneumoniaTomography, X-Ray ComputedBrain NeoplasmsRadiationLungRetrospective StudiesFollow-Up StudiesRadiation ProtectionRadiography, ThoracicGoserelinDisease-Free SurvivalNeoplasm StagingLymphatic IrradiationCisplatinRadiation MonitoringAmifostineChemotherapy, AdjuvantNeoplasm Recurrence, LocalCarcinoma, Squamous CellOncology NursingSurvival RateTime FactorsRectumPrognosisPelvisClinical Trials, Phase III as TopicAnus NeoplasmsTumor BurdenFlutamideGlioblastomaFluorouracilProportional Hazards ModelsAdenocarcinomaRadiometryProstate-Specific AntigenNeoplasms, Radiation-InducedMultivariate AnalysisLung Diseases, InterstitialRadiation-Sensitizing AgentsClinical Trials as TopicKaplan-Meier EstimateNeoplasmsCosmic RadiationGamma RaysRadiotherapy, Computer-AssistedDrug Administration SchedulePaclitaxelFeasibility StudiesMaximum Tolerated DoseNeoadjuvant TherapyRadiation-Protective AgentsRadiodermatitisAntineoplastic Agents, HormonalRandomized Controlled Trials as Topic